Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine Add-On in Bipolar Disorder and Alcohol Abuse/Dependence
NCT00223249Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Nov 2002
- Primary completion
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bipolar disorder (BD), alcohol use disorder (AUD) and alcohol dependence comparing Quetiapine Add-On with Placebo Add-On (2 arms). Primary endpoint: Number of Standard Drinks. Started Nov 2002; status: completed.
02
Drugs
quetiapine
03
Conditions
bipolar disorder (BD)alcohol use disorder (AUD)alcohol dependence
Beyond the preview
Go deeper on NCT00223249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00223249.